Search

TNF Muteins and Uses Thereof

USPTO granted Patent US12605425B2 to Oxford University Innovation Limited for tumour necrosis factor (TNF) muteins that function as selective agonists of tumour necrosis factor receptor 1 (TNFR1). The patent covers compositions comprising these TNF muteins, methods of treating or detecting tumours, and related nucleic acids and host cells. This is a routine patent grant conferring exclusive rights to the assignee with no immediate compliance obligations for other parties.